Zwitterionic Polymer-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Low Protein Interaction and High Biocompatibility

Pombo-Garcia, K; Weiss, S; Zarschler, K; Ang, CS; Huebner, R; Pufe, J; Meister, S; Seidel, J; Pietzsch, J; Spiccia, L; Stephan, H; Graham, Bim

HERO ID

4936829

Reference Type

Journal Article

Year

2016

HERO ID 4936829
In Press No
Year 2016
Title Zwitterionic Polymer-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Low Protein Interaction and High Biocompatibility
Authors Pombo-Garcia, K; Weiss, S; Zarschler, K; Ang, CS; Huebner, R; Pufe, J; Meister, S; Seidel, J; Pietzsch, J; Spiccia, L; Stephan, H; Graham, Bim
Volume 2
Issue 10
Page Numbers 959-971
Abstract We report the synthesis and detailed in vitro evaluation of zwitterionic ultrasmall superparamagnetic iron oxide NPs (USPIONs) comprising oleic acid/oleyl alcohol-stabilized magnetite particles (5 nm core diameter) coated with an amphiphilic zwitterionic polymer, poly(maleic anhydridealt-1-decene) substituted with 3-(dimethylamino) propylamine (PMAL). These particles display a near-neutral zeta potential at pH >= 7 and possess high colloidal stability, maintaining a hydrodynamic diameter of ca. 15-20 nm over a wide range of pHs (4-10) and ionic strength (up to 1m NaCl). They exhibit very low levels of nonspecific protein binding upon exposure to serum, and negligible uptake by phagocytic and non-phagocytic hepatocarcinoma cells, which suggests that they may be able to resist rapid accumulation in the liver and spleen, a common in vivo fate for NPs. The PMAL-USPIONs exhibit very low cytotoxicity and do not elicit an inflammatory response or display hemolytic activity in vitro. Minimal nonspecific uptake by either cancerous or non-cancerous cell lines was observed, an important precondition to achieve highly selective targeting upon further functionalization with an active targeting agent (e.g., antibody or peptide). Overall, this study establishes the considerable potential of PMAL-USPIONs as a platform for the future development of "stealth" NP-based imaging and/or therapeutic agents.
Doi 10.1002/cnma.201600233
Wosid WOS:000387680000006
Is Certified Translation No
Dupe Override No
Comments Journal:CHEMNANOMAT 2199-692X
Is Public Yes
Keyword iron oxide nanoparticles; macrophages; protein corona; proteomics; zwitterionic coatings